Wolfjaw Lodge, part of the White Rainbow hospitality group, today announced the completion of its comprehensive property renovation and brand refresh. Previously called The Alpine Country Inn and ...

Research by The Athletic for two-night stays around World Cup games in the 16 host cities has revealed huge price hikes ...

The Poconos in Pennsylvania offers some of the most breathtaking natural beauty in the country, and this scenic hotel lets ...

De Lesseps was slammed by fans over her holiday performance on Peacock's debut of Reality Hot Seat on Sunday night.

Karel Arrowhead, initially labelled as Sleeping Man in-game is an NPC in the Kuttenberg region of KCD2. However, he is only available to meet as a random event after the Speak of the Devil main ...

Kansas City Chiefs tight end Travis Kelce (87) and Taylor Swift walk off the field after the trophy ceremony following the ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Arrowhead defeated Bay Port 18-15 to win the WIAA Division 1 state football championship. Ryan Heiman returned a kickoff 76 yards for the winning touchdown with 35 seconds remaining. Bay Port chose to ...

FDA approved Plozasiran (now REDEMPLO™) on November 18, 2025, for reducing triglycerides in adults with FCS, the first siRNA therapy for this rare disease. ARWR boasts a diversified RNAi pipeline ...

Armed with a first commercial win, Arrowhead is already casting an eye to its portfolio’s future success. Credit: Vanz Studio via Shutterstock.com. Arrowhead Pharmaceuticals has hit the bullseye with ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles ...